Use of tyrosine kinase inhibitor by patients with chronic myeloid leukemia at a public hematology institution in the state of Amazonas, Brazil
Objectives: To evaluate the conditions of use of tyrosine kinase inhibitors and adherence by patients with chronic myeloid leukemia treated at a public hematology institution. Methods: This was an observational and cross-sectional study carried out from December 2015 to April 2016. Data collection...
Guardado en:
Autores principales: | Andreia D. MENEZES, Nelson A. FRAIJI |
---|---|
Formato: | article |
Lenguaje: | EN PT |
Publicado: |
Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c52459a0d67b4e00b41a6f027260a831 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New Compounds with Bioisosteric Replacement of Classic Choline Kinase Inhibitors Show Potent Antiplasmodial Activity
por: Francisco José Aguilar-Troyano, et al.
Publicado: (2021) -
Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
por: Takahito Kawano, et al.
Publicado: (2021) -
Guest editorial: The ten most important qualities for the profession of medicinal research
por: Tony Y. Zhang
Publicado: (2021) -
Correction: Structural Racism and Supporting Black Lives – A Pharmacist’s Vow amid COVID-19
por: Nicole D. Avant
Publicado: (2021) -
An Overview of COVID-19 Vaccine Safety and Post-marketing Surveillance Systems
por: Manal Mohammed Younus, et al.
Publicado: (2021)